Metsera is a new GLP-1 player with a Phase 2b injectable and promising oral and amylin drugs in development. Learn why MTSR ...

Novo Nordisk is collaborating with multiple telehealth organizations in an effort to increase patient access to authentic Wegovy.

The FDA has accepted for review the New Drug Application for a 25mg oral formulation of semaglutide for chronic weight management.